These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6217772)

  • 1. Alzheimer's disease and Down's syndrome.
    Price DL; Whitehouse PJ; Struble RG; Coyle JT; Clark AW; Delong MR; Cork LC; Hedreen JC
    Ann N Y Acad Sci; 1982; 396():145-64. PubMed ID: 6217772
    [No Abstract]   [Full Text] [Related]  

  • 2. Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome.
    Yates CM; Simpson J; Gordon A; Maloney AF; Allison Y; Ritchie IM; Urquhart A
    Brain Res; 1983 Nov; 280(1):119-26. PubMed ID: 6228286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional brain 5-hydroxytryptamine levels are reduced in senile Down's syndrome as in Alzheimer's disease.
    Yates CM; Simpson J; Gordon A
    Neurosci Lett; 1986 Apr; 65(2):189-92. PubMed ID: 2940479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence against the involvement of reactive oxygen species in the pathogenesis of neuronal death in Down's syndrome and Alzheimer's disease.
    Hayn M; Kremser K; Singewald N; Cairns N; Nemethova M; Lubec B; Lubec G
    Life Sci; 1996; 59(7):537-44. PubMed ID: 8761342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue.
    Godridge H; Reynolds GP; Czudek C; Calcutt NA; Benton M
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):775-8. PubMed ID: 2440994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down's syndrome and Alzheimer's dementia: defining an association.
    Heston LL
    Psychiatr Dev; 1984; 2(4):287-94. PubMed ID: 6241313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dementia of Down's syndrome and its relevance to aetiological studies of Alzheimer's disease.
    Whalley LJ
    Ann N Y Acad Sci; 1982; 396():39-53. PubMed ID: 6217776
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemistry of Alzheimer's dementia.
    Marchbanks RM
    J Neurochem; 1982 Jul; 39(1):9-15. PubMed ID: 6806445
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome.
    Nunomura A; Perry G; Hirai K; Aliev G; Takeda A; Chiba S; Smith MA
    Ann N Y Acad Sci; 1999; 893():362-4. PubMed ID: 10672267
    [No Abstract]   [Full Text] [Related]  

  • 10. Discrepancy between Alzheimer-type neuropathology and dementia in persons with Down's syndrome.
    Wisniewski HM; Rabe A
    Ann N Y Acad Sci; 1986; 477():247-60. PubMed ID: 2949682
    [No Abstract]   [Full Text] [Related]  

  • 11. Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis.
    Griffin WS; Sheng JG; McKenzie JE; Royston MC; Gentleman SM; Brumback RA; Cork LC; Del Bigio MR; Roberts GW; Mrak RE
    Neurobiol Aging; 1998; 19(5):401-5. PubMed ID: 9880042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral amyloidosis, ageing and Alzheimer's disease; a contribution from studies on Down's syndrome.
    Mann DM
    Neurobiol Aging; 1989; 10(5):397-9; discussion 412-4. PubMed ID: 2530459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choline acetyltransferase and acetylcholinesterase abnormalities in senile dementia: importance of biochemical measurements in human post-mortem brain specimens.
    Sorbi S; Antuono P; Amaducci L
    Ital J Neurol Sci; 1980 Mar; 1(2):75-83. PubMed ID: 7040296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down's syndrome individuals begin life with normal levels of brain cholinergic markers.
    Kish S; Karlinsky H; Becker L; Gilbert J; Rebbetoy M; Chang LJ; DiStefano L; Hornykiewicz O
    J Neurochem; 1989 Apr; 52(4):1183-7. PubMed ID: 2522539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small cerebral hemispheres in adults with Down's syndrome: contributions of developmental arrest and lesions of Alzheimer's disease.
    de la Monte SM; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1990 Sep; 49(5):509-20. PubMed ID: 2148772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
    Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
    Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topographic relationship between neurofibrillary change and acetylcholinesterase rich neurons in the upper brain stem of patients with senile dementia of the Alzheimer's type and Down's syndrome.
    Shortridge BA; Vogel FS; Burger PC
    Clin Neuropathol; 1985; 4(6):227-37. PubMed ID: 2934202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic enzymes in the spinal cord in Alzheimer-type dementia.
    Yates CM; Simpson J; Gordon A; Christie JE
    J Neural Transm Park Dis Dement Sect; 1989; 1(4):311-5. PubMed ID: 2532018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer-like cholinergic deficiency in Down syndrome.
    Yates CM; Simpson J; Maloney AF; Gordon A; Reid AH
    Lancet; 1980 Nov; 2(8201):979. PubMed ID: 6107618
    [No Abstract]   [Full Text] [Related]  

  • 20. The cholinergic system in old age and Alzheimer's disease.
    Perry EK
    Age Ageing; 1980 Feb; 9(1):1-8. PubMed ID: 7361631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.